To combat viruses, one of humankind's oldest threats, researchers are studying predators with the oldest adaptive immune system in the animal kingdom: sharks.
Jun 1, 2022
0
102
Scientists at La Jolla Institute for Immunology (LJI) have published the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2. Their in-depth look at how T cells, B cells, antibody levels ...
May 31, 2022
1
148
The first three coronavirus vaccines earned Emergency Use Authorization more than a year ago. To date, no other vaccines have been put into use in the U.S—but that will soon change. More than 40 vaccines are undergoing ...
May 5, 2022
0
119
Getting sick with a common cold doesn't make you immune to COVID-19, but a COVID-19 infection might, at least temporarily, boost the number of antibodies you have against common cold-causing coronaviruses and the SARS-CoV-1 ...
May 5, 2022
0
110
The omicron variant of SARS-CoV-2 has caused another major wave of infection worldwide. This is because even vaccinated individuals or those who had contracted a previous variant of the virus can become infected with omicron. ...
May 2, 2022
0
107
A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human clinical trials to treat ...
Apr 13, 2022
0
155
A group of bat viruses related to SARS-CoV-2 can also infect human cells but uses a different and unknown entryway.
Apr 8, 2022
0
102
As the effort to combat the SARS-CoV-2 virus began, among the most pressing questions were how to gauge its infectivity and get a better picture of those dynamics from the inside out. Answering them initially would bring ...
Mar 15, 2022
0
87
There is a lack of understanding as to why some people suffer from long-lasting symptoms after COVID-19 infection. A new study from Karolinska Institutet in Sweden, and the Helmholtz Center Munich (HMGU) and the Technical ...
Mar 14, 2022
0
230
Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists ...
Feb 25, 2022
2
292
